Health PR
Global Insights: Patient Advocacy Trends
Patient advocacy is no longer a ‘nice to have’. Rather, it’s reshaping reimbursement decisions, policy influence & healthcare communications strategies worldwide. 🌎 As the exclusive Australian partner of @Global Health Marketing & Communications (GHMC), VIVA! Communications proudly contributed to the launch of GHMC’s landmark report, Global Insights: Patient Advocacy Trends – drawing on perspectives from…
Read MoreMemory loss isn’t “normal”: closing Australia’s Alzheimer’s diagnosis gap
Australia is entering a new era of ageing. By 2026, life expectancy is projected to reach 84.3 years – among the highest worldwide. But longevity comes with urgency: dementia, including Alzheimer’s disease, is now Australia’s leading cause of death, accounting for 9.4% of all fatalities. More than 446,000 Australians are currently living with dementia –…
Read MoreBeyond the seizure: rethinking epilepsy care from crisis response to risk prevention
For most chronic diseases, prevention is central to the conversation. In epilepsy, however, the system still largely reacts. Across Australia, an estimated 266,000 people are living with epilepsy, yet public understanding of the disease often begins and ends with the visible seizure. In many cases, care pathways still form around acut e events –…
Read MoreVisualising complex science for maximum impact
In healthcare communications, some of the most important messages are decided before a single word is read. Scientific evidence, regulatory nuance, and patient impact demand careful explanation. Yet audiences scan, interpret, and react visually first. Visual communication acts as a shortcut to clarity, allowing complex ideas to be understood quickly and intuitively. Unlike written language,…
Read MoreRare but rarely recognised: Accelerating diagnosis, access, & innovation for rare diseases in Australia & APAC
Two million Australians are living with a rare disease, yet diagnosis can take five-to-seven years. Across APAC, fragmented systems, limited awareness, and uneven access to therapies create both challenges and opportunities for pharma, biotech, and medtech innovators. This Rare Disease Day, it’s time to move from awareness to action, shortening diagnostic journeys, improving access, and…
Read More